TY - JOUR
T1 - Replication of recently identified systemic lupus erythematosus genetic associations
T2 - a case-control study
AU - Suarez-Gestal, Marian
AU - Calaza, Manuel
AU - Endreffy, Emoeke
AU - Pullmann, Rudolf
AU - Ordi-Ros, Josep
AU - Sebastiani, Gian Domenico
AU - Ruzickova, Sarka
AU - Santos, Maria Jose
AU - Papasteriades, Chryssa
AU - Marchini, Maurizio
AU - Skopouli, Fotini N.
AU - Suarez, Ana
AU - Blanco, Francisco J.
AU - D'Alfonso, Sandra
AU - Bijl, Marc
AU - Carreira, Patricia
AU - Witte, Torsten
AU - Migliaresi, Sergio
AU - Gomez-Reino, Juan J.
AU - Gonzalez, Antonio
AU - European Consortium SLE DNA
PY - 2009/5/14
Y1 - 2009/5/14
N2 - Introduction We aimed to replicate association of newly identified systemic lupus erythematosus (SLE) loci.Methods We selected the most associated SNP in 10 SLE loci. These 10 SNPs were analysed in 1,579 patients with SLE and 1,726 controls of European origin by single-base extension. Comparison of allele frequencies between cases and controls was done with the Mantel-Haenszel approach to account for heterogeneity between sample collections.Results A previously controversial association with a SNP in the TYK2 gene was replicated (odds ratio (OR) = 0.79, P = 2.5 x 10(-5)), as well as association with the X chromosome MECP2 gene (OR = 1.26, P = 0.00085 in women), which had only been reported in a single study, and association with four other loci, 1q25.1 (OR = 0.81, P = 0.0001), PXK (OR = 1.19, P = 0.0038), BANK1 (OR = 0.83, P = 0.006) and KIAA1542 (OR = 0.84, P = 0.001), which have been identified in a genome-wide association study, but not found in any other study. All these replications showed the same disease-associated allele as originally reported. No association was found with the LY9 SNP, which had been reported in a single study.Conclusions Our results confirm nine SLE loci. For six of them, TYK2, MECP2, 1q25.1, PXK, BANK1 and KIAA1542, this replication is important. The other three loci, ITGAM, STAT4 and C8orf13-BLK, were already clearly confirmed. Our results also suggest that MECP2 association has no influence in the sex bias of SLE, contrary to what has been proposed. In addition, none of the other associations seems important in this respect.
AB - Introduction We aimed to replicate association of newly identified systemic lupus erythematosus (SLE) loci.Methods We selected the most associated SNP in 10 SLE loci. These 10 SNPs were analysed in 1,579 patients with SLE and 1,726 controls of European origin by single-base extension. Comparison of allele frequencies between cases and controls was done with the Mantel-Haenszel approach to account for heterogeneity between sample collections.Results A previously controversial association with a SNP in the TYK2 gene was replicated (odds ratio (OR) = 0.79, P = 2.5 x 10(-5)), as well as association with the X chromosome MECP2 gene (OR = 1.26, P = 0.00085 in women), which had only been reported in a single study, and association with four other loci, 1q25.1 (OR = 0.81, P = 0.0001), PXK (OR = 1.19, P = 0.0038), BANK1 (OR = 0.83, P = 0.006) and KIAA1542 (OR = 0.84, P = 0.001), which have been identified in a genome-wide association study, but not found in any other study. All these replications showed the same disease-associated allele as originally reported. No association was found with the LY9 SNP, which had been reported in a single study.Conclusions Our results confirm nine SLE loci. For six of them, TYK2, MECP2, 1q25.1, PXK, BANK1 and KIAA1542, this replication is important. The other three loci, ITGAM, STAT4 and C8orf13-BLK, were already clearly confirmed. Our results also suggest that MECP2 association has no influence in the sex bias of SLE, contrary to what has been proposed. In addition, none of the other associations seems important in this respect.
KW - GENOME-WIDE ASSOCIATION
KW - RHEUMATOID-ARTHRITIS
KW - VARIANTS
KW - RISK
KW - STAT4
KW - SUSCEPTIBILITY
KW - POLYMORPHISMS
KW - ITGAM
KW - MECP2
KW - SLE
U2 - 10.1186/ar2698
DO - 10.1186/ar2698
M3 - Article
C2 - 19442287
SN - 1478-6354
VL - 11
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
IS - 3
M1 - 69
ER -